查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886330

電子處方市場－全球產業規模、佔有率、趨勢、機會和預測，按產品（解決方案）、服務、專業領域、給藥方式、藥物成分、地區和競爭格局分類，2020-2030年預測

E-Prescribing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Solutions ), Services, By Specialties, By Delivery Mode, By Substances, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球電子處方市場規模為29.4億美元，預計到2030年將以8.39%的複合年成長率成長至47.7億美元。電子處方是指以電子方式產生、傳輸和執行醫療處方，取代傳統的紙本處方方式，從而提高效率和病人安全。推動市場擴張的主要因素包括：整合電子健康記錄解決方案的日益普及、政府推廣數位醫療的舉措，以及減少用藥錯誤和打擊管制藥物濫用的迫切需求。

市場概覽
預測期 2026-2030
市場規模：2024年 29.4億美元
市場規模：2030年 47.7億美元
複合年成長率：2025-2030年 8.39%
成長最快的細分市場 解決方案
最大的市場 北美洲

主要市場促進因素

整合式電子健康記錄 (EHR) 系統的日益普及，透過建立處方工作流程的數位基礎設施，從根本上推動了全球電子處方市場的發展。當電子處方功能嵌入到全面的 EHR 平台中時，醫療服務提供者可以存取患者病史、過敏資訊和用藥清單，從而實現更明智、更安全的處方。

主要市場挑戰

阻礙全球電子處方市場擴張的一大挑戰是互通性這一長期存在的問題。不同的電子健康記錄和藥房系統往往缺乏無縫通訊能力，導致患者資料分散，效率低。

主要市場趨勢

市場正見證著人工智慧驅動的臨床決策支援系統整合的顯著趨勢，這些系統正超越傳統的基於規則的警報，嵌入複雜的人工智慧和機器學習功能。這些先進系統旨在分析大量的患者資料，包括完整的病史、基因組資訊和即時生物特徵數據，從而產生高度個人化的治療建議。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球電子處方市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（解決方案、服務）分類
    • 按專科（腫瘤科、運動醫學科、神經科、心臟科、其他）
    • 依交付方式（基於 Web/雲端、本機部署）
    • 依物質分類（管制物質、非管制物質）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美電子處方市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲電子處方市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區電子處方市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲電子處方市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美電子處方市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球電子處方市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Oracle Corporation
  • Veradigm LLC
  • Epic Systems Corporation
  • Athenahealth, Inc.
  • NextGen Healthcare, Inc.
  • McKesson Corporation
  • Surescripts, LLC
  • Change Healthcare LLC
  • Practice Fusion, Inc.
  • Networking Technology, Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22466

The Global E-Prescribing Market, valued at USD 2.94 Billion in 2024, is projected to experience a CAGR of 8.39% to reach USD 4.77 Billion by 2030. E-prescribing refers to the electronic generation, transmission, and fulfillment of medical prescriptions, replacing traditional paper-based methods to enhance efficiency and patient safety. The market's expansion is fundamentally driven by the increasing adoption of integrated electronic health record solutions, governmental initiatives promoting digital health, and a critical need to mitigate medication errors and combat controlled substance abuse.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.94 Billion
Market Size 2030USD 4.77 Billion
CAGR 2025-20308.39%
Fastest Growing SegmentSolutions
Largest MarketNorth America

Key Market Drivers

The increasing adoption of integrated Electronic Health Record (EHR) systems fundamentally drives the global e-prescribing market by establishing a digital infrastructure for prescription workflows. When e-prescribing is embedded within comprehensive EHR platforms, healthcare providers access patient histories, allergy information, and medication lists, enabling informed and safer prescribing. This integration boosts clinical efficiency and care coordination, streamlining the entire medication management process.

Key Market Challenges

A significant challenge impeding the global e-prescribing market expansion is the persistent issue of interoperability. Disparate electronic health record and pharmacy systems frequently lack seamless communication capabilities, resulting in fragmented patient data and substantial inefficiencies. This fragmentation creates data silos, preventing comprehensive patient information exchange necessary for accurate and safe medication management across the healthcare continuum.

Key Market Trends

The market is observing a significant trend in the integration of AI-powered clinical decision support systems, moving beyond conventional rule-based alerts to embed sophisticated artificial intelligence and machine learning capabilities. These advanced systems are engineered to analyze extensive patient data, including comprehensive medical histories, genomic information, and real-time biometric inputs, to generate highly personalized treatment recommendations. This enables prescribers to anticipate potential drug interactions with enhanced accuracy, identify subtle disease progression patterns, and tailor medication regimens precisely to individual patient needs. The integration of such intelligent tools signifies a fundamental shift towards a more proactive and data-driven approach to patient care, where decision support is not merely reactive but predictive.

Key Market Players

  • Oracle Corporation
  • Veradigm LLC
  • Epic Systems Corporation
  • Athenahealth, Inc.
  • NextGen Healthcare, Inc.
  • McKesson Corporation
  • Surescripts, LLC
  • Change Healthcare LLC
  • Practice Fusion, Inc.
  • Networking Technology, Inc.

Report Scope:

In this report, the Global E-Prescribing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

E-Prescribing Market, By Product:

  • Solutions
  • Services

E-Prescribing Market, By Specialties:

  • Oncology
  • Sports Medicine
  • Neurology
  • Cardiology
  • Others

E-Prescribing Market, By Delivery Mode:

  • Web/Cloud Based
  • On Premise

E-Prescribing Market, By Substances:

  • Controlled Substances
  • Non-controlled Substances

E-Prescribing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global E-Prescribing Market.

Available Customizations:

Global E-Prescribing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global E-Prescribing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Solutions, Services)
    • 5.2.2. By Specialties (Oncology, Sports Medicine, Neurology, Cardiology, Others)
    • 5.2.3. By Delivery Mode (Web/Cloud Based, On Premise)
    • 5.2.4. By Substances (Controlled Substances, Non-controlled Substances)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America E-Prescribing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Specialties
    • 6.2.3. By Delivery Mode
    • 6.2.4. By Substances
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States E-Prescribing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Specialties
        • 6.3.1.2.3. By Delivery Mode
        • 6.3.1.2.4. By Substances
    • 6.3.2. Canada E-Prescribing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Specialties
        • 6.3.2.2.3. By Delivery Mode
        • 6.3.2.2.4. By Substances
    • 6.3.3. Mexico E-Prescribing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Specialties
        • 6.3.3.2.3. By Delivery Mode
        • 6.3.3.2.4. By Substances

7. Europe E-Prescribing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Specialties
    • 7.2.3. By Delivery Mode
    • 7.2.4. By Substances
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany E-Prescribing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Specialties
        • 7.3.1.2.3. By Delivery Mode
        • 7.3.1.2.4. By Substances
    • 7.3.2. France E-Prescribing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Specialties
        • 7.3.2.2.3. By Delivery Mode
        • 7.3.2.2.4. By Substances
    • 7.3.3. United Kingdom E-Prescribing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Specialties
        • 7.3.3.2.3. By Delivery Mode
        • 7.3.3.2.4. By Substances
    • 7.3.4. Italy E-Prescribing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Specialties
        • 7.3.4.2.3. By Delivery Mode
        • 7.3.4.2.4. By Substances
    • 7.3.5. Spain E-Prescribing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Specialties
        • 7.3.5.2.3. By Delivery Mode
        • 7.3.5.2.4. By Substances

8. Asia Pacific E-Prescribing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Specialties
    • 8.2.3. By Delivery Mode
    • 8.2.4. By Substances
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China E-Prescribing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Specialties
        • 8.3.1.2.3. By Delivery Mode
        • 8.3.1.2.4. By Substances
    • 8.3.2. India E-Prescribing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Specialties
        • 8.3.2.2.3. By Delivery Mode
        • 8.3.2.2.4. By Substances
    • 8.3.3. Japan E-Prescribing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Specialties
        • 8.3.3.2.3. By Delivery Mode
        • 8.3.3.2.4. By Substances
    • 8.3.4. South Korea E-Prescribing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Specialties
        • 8.3.4.2.3. By Delivery Mode
        • 8.3.4.2.4. By Substances
    • 8.3.5. Australia E-Prescribing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Specialties
        • 8.3.5.2.3. By Delivery Mode
        • 8.3.5.2.4. By Substances

9. Middle East & Africa E-Prescribing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Specialties
    • 9.2.3. By Delivery Mode
    • 9.2.4. By Substances
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia E-Prescribing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Specialties
        • 9.3.1.2.3. By Delivery Mode
        • 9.3.1.2.4. By Substances
    • 9.3.2. UAE E-Prescribing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Specialties
        • 9.3.2.2.3. By Delivery Mode
        • 9.3.2.2.4. By Substances
    • 9.3.3. South Africa E-Prescribing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Specialties
        • 9.3.3.2.3. By Delivery Mode
        • 9.3.3.2.4. By Substances

10. South America E-Prescribing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Specialties
    • 10.2.3. By Delivery Mode
    • 10.2.4. By Substances
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil E-Prescribing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Specialties
        • 10.3.1.2.3. By Delivery Mode
        • 10.3.1.2.4. By Substances
    • 10.3.2. Colombia E-Prescribing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Specialties
        • 10.3.2.2.3. By Delivery Mode
        • 10.3.2.2.4. By Substances
    • 10.3.3. Argentina E-Prescribing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Specialties
        • 10.3.3.2.3. By Delivery Mode
        • 10.3.3.2.4. By Substances

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global E-Prescribing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Oracle Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Veradigm LLC
  • 15.3. Epic Systems Corporation
  • 15.4. Athenahealth, Inc.
  • 15.5. NextGen Healthcare, Inc.
  • 15.6. McKesson Corporation
  • 15.7. Surescripts, LLC
  • 15.8. Change Healthcare LLC
  • 15.9. Practice Fusion, Inc.
  • 15.10. Networking Technology, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer